214 related articles for article (PubMed ID: 28916769)
1. Therapeutic effects of the mitochondrial ROS-redox modulator KH176 in a mammalian model of Leigh Disease.
de Haas R; Das D; Garanto A; Renkema HG; Greupink R; van den Broek P; Pertijs J; Collin RWJ; Willems P; Beyrath J; Heerschap A; Russel FG; Smeitink JA
Sci Rep; 2017 Sep; 7(1):11733. PubMed ID: 28916769
[TBL] [Abstract][Full Text] [Related]
2. Effects of clofibrate and KH176 on life span and motor function in mitochondrial complex I-deficient mice.
Frambach SJCM; van de Wal MAE; van den Broek PHH; Smeitink JAM; Russel FGM; de Haas R; Schirris TJJ
Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165727. PubMed ID: 32070771
[TBL] [Abstract][Full Text] [Related]
3. KH176 Safeguards Mitochondrial Diseased Cells from Redox Stress-Induced Cell Death by Interacting with the Thioredoxin System/Peroxiredoxin Enzyme Machinery.
Beyrath J; Pellegrini M; Renkema H; Houben L; Pecheritsyna S; van Zandvoort P; van den Broek P; Bekel A; Eftekhari P; Smeitink JAM
Sci Rep; 2018 Apr; 8(1):6577. PubMed ID: 29700325
[TBL] [Abstract][Full Text] [Related]
4. PKC downregulation upon rapamycin treatment attenuates mitochondrial disease.
Martin-Perez M; Grillo AS; Ito TK; Valente AS; Han J; Entwisle SW; Huang HZ; Kim D; Yajima M; Kaeberlein M; Villén J
Nat Metab; 2020 Dec; 2(12):1472-1481. PubMed ID: 33324011
[TBL] [Abstract][Full Text] [Related]
5. Targeting NAD
Lee CF; Caudal A; Abell L; Nagana Gowda GA; Tian R
Sci Rep; 2019 Feb; 9(1):3073. PubMed ID: 30816177
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia ameliorates brain hyperoxia and NAD
Grange RMH; Sharma R; Shah H; Reinstadler B; Goldberger O; Cooper MK; Nakagawa A; Miyazaki Y; Hindle AG; Batten AJ; Wojtkiewicz GR; Schleifer G; Bagchi A; Marutani E; Malhotra R; Bloch DB; Ichinose F; Mootha VK; Zapol WM
Mol Genet Metab; 2021 May; 133(1):83-93. PubMed ID: 33752971
[TBL] [Abstract][Full Text] [Related]
7. Ndufs4 knockout mouse models of Leigh syndrome: pathophysiology and intervention.
van de Wal MAE; Adjobo-Hermans MJW; Keijer J; Schirris TJJ; Homberg JR; Wieckowski MR; Grefte S; van Schothorst EM; van Karnebeek C; Quintana A; Koopman WJH
Brain; 2022 Mar; 145(1):45-63. PubMed ID: 34849584
[TBL] [Abstract][Full Text] [Related]
8. Gait analysis in a mouse model resembling Leigh disease.
de Haas R; Russel FG; Smeitink JA
Behav Brain Res; 2016 Jan; 296():191-198. PubMed ID: 26363424
[TBL] [Abstract][Full Text] [Related]
9. mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome.
Johnson SC; Yanos ME; Kayser EB; Quintana A; Sangesland M; Castanza A; Uhde L; Hui J; Wall VZ; Gagnidze A; Oh K; Wasko BM; Ramos FJ; Palmiter RD; Rabinovitch PS; Morgan PG; Sedensky MM; Kaeberlein M
Science; 2013 Dec; 342(6165):1524-8. PubMed ID: 24231806
[TBL] [Abstract][Full Text] [Related]
10. Acarbose suppresses symptoms of mitochondrial disease in a mouse model of Leigh syndrome.
Bitto A; Grillo AS; Ito TK; Stanaway IB; Nguyen BMG; Ying K; Tung H; Smith K; Tran N; Velikanje G; Urfer SR; Snyder JM; Barton J; Sharma A; Kayser EB; Wang L; Smith DL; Thompson JW; DuBois L; DePaolo W; Kaeberlein M
Nat Metab; 2023 Jun; 5(6):955-967. PubMed ID: 37365290
[TBL] [Abstract][Full Text] [Related]
11. Regional metabolic signatures in the Ndufs4(KO) mouse brain implicate defective glutamate/α-ketoglutarate metabolism in mitochondrial disease.
Johnson SC; Kayser EB; Bornstein R; Stokes J; Bitto A; Park KY; Pan A; Sun G; Raftery D; Kaeberlein M; Sedensky MM; Morgan PG
Mol Genet Metab; 2020 Jun; 130(2):118-132. PubMed ID: 32331968
[TBL] [Abstract][Full Text] [Related]
12. Quantifying small molecule phenotypic effects using mitochondrial morpho-functional fingerprinting and machine learning.
Blanchet L; Smeitink JA; van Emst-de Vries SE; Vogels C; Pellegrini M; Jonckheere AI; Rodenburg RJ; Buydens LM; Beyrath J; Willems PH; Koopman WJ
Sci Rep; 2015 Jan; 5():8035. PubMed ID: 25620325
[TBL] [Abstract][Full Text] [Related]
13. Double administration of self-complementary AAV9NDUFS4 prevents Leigh disease in Ndufs4-/- mice.
Corrà S; Cerutti R; Balmaceda V; Viscomi C; Zeviani M
Brain; 2022 Oct; 145(10):3405-3414. PubMed ID: 36270002
[TBL] [Abstract][Full Text] [Related]
14. Iron status influences mitochondrial disease progression in Complex I-deficient mice.
Kelly CJ; Couch RK; Ha VT; Bodart CM; Wu J; Huff S; Herrel NT; Kim HD; Zimmermann AO; Shattuck J; Pan YC; Kaeberlein M; Grillo AS
Elife; 2023 Feb; 12():. PubMed ID: 36799301
[TBL] [Abstract][Full Text] [Related]
15. Ndufs4 KO mice: A model to study comorbid mood disorders associated with mitochondrial dysfunction.
van Rensburg DJ; Lindeque Z; Harvey BH; Steyn SF
Pharmacol Biochem Behav; 2024 Jan; 234():173689. PubMed ID: 38070656
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma contributes to disease progression in the Ndufs4(-/-) model of Leigh syndrome.
Hanaford AR; Khanna A; James K; Truong V; Liao R; Chen Y; Mulholland M; Kayser EB; Watanabe K; Hsieh ES; Sedensky M; Morgan PG; Kalia V; Sarkar S; Johnson SC
Neuropathol Appl Neurobiol; 2024 Jun; 50(3):e12977. PubMed ID: 38680020
[TBL] [Abstract][Full Text] [Related]
17. Tetracyclines promote survival and fitness in mitochondrial disease models.
Perry EA; Bennett CF; Luo C; Balsa E; Jedrychowski M; O'Malley KE; Latorre-Muro P; Ladley RP; Reda K; Wright PM; Gygi SP; Myers AG; Puigserver P
Nat Metab; 2021 Jan; 3(1):33-42. PubMed ID: 33462515
[TBL] [Abstract][Full Text] [Related]
18. The NDUFS4 Knockout Mouse: A Dual Threat Model of Childhood Mitochondrial Disease and Normative Aging.
Grillo AS; Bitto A; Kaeberlein M
Methods Mol Biol; 2021; 2277():143-155. PubMed ID: 34080150
[TBL] [Abstract][Full Text] [Related]
19. Elevated susceptibility to exogenous seizure triggers and impaired interneuron excitability in a mouse model of Leigh syndrome epilepsy.
Manning A; Han V; Stephens A; Wang R; Bush N; Bard M; Ramirez JM; Kalume F
Neurobiol Dis; 2023 Oct; 187():106288. PubMed ID: 37704057
[TBL] [Abstract][Full Text] [Related]
20. KH176 under development for rare mitochondrial disease: a first in man randomized controlled clinical trial in healthy male volunteers.
Koene S; Spaans E; Van Bortel L; Van Lancker G; Delafontaine B; Badilini F; Beyrath J; Smeitink J
Orphanet J Rare Dis; 2017 Oct; 12(1):163. PubMed ID: 29037240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
